Recruiting Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569 Conditions Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Female Urogenital Diseases, +22 more Locations Grady Health System — Atlanta, Georgia, United States Emory University Hospital Midtown — Atlanta, Georgia, United States Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States Emory Saint Joseph's Hospital — Atlanta, Georgia, United States View Trial Details